Navigation Links
Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
Date:8/6/2012

ROCHESTER, N.Y., Aug. 6, 2012 /PRNewswire/ -- Bausch & Lomb Incorporated ("Bausch + Lomb") announced today an amendment to its previously announced tender offer (the "tender offer") to purchase for cash up to $300 million of its outstanding 9 ⅞ percent Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8) (the "senior notes").

Bausch + Lomb is extending the previously announced "early tender date" of 5 p.m., New York City time, on August 3, 2012, to 11:59 p.m., New York City time, on August 17, 2012, which is also the previously announced expiration date (such time and date, as the same may be extended or earlier terminated, the "expiration date") for the tender offer.  All other terms of the tender offer remain unchanged.

Accordingly, holders of senior notes who validly tender their senior notes before the expiration date will be eligible to receive the previously announced "total consideration" of $1,041.25 per $1,000 principal amount of senior notes purchased.

The previously announced withdrawal deadline of 5 p.m., New York City time, on August 3, 2012 has passed.  As a result, holders who have previously tendered senior notes and those holders who tender senior notes on or before the expiration date may not withdraw those notes.

The obligation of Bausch + Lomb to accept for purchase, and to pay for, senior notes validly tendered pursuant to the tender offer is subject to, and conditioned upon, the satisfaction or waiver of certain conditions as set forth in the Bausch + Lomb Offer to Purchase dated July 23, 2012, including completion of the drawdown of Bausch + Lomb's delayed draw term loan and other customary conditions.

The complete terms and conditions of the tender offer are described in the Bausch + Lomb Offer to Purchase dated July 23, 2012, copies of which may be obtained by contacting Global Bondholder Services Corporation, which is acting as the tender and information
'/>"/>

SOURCE Bausch + Lomb
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Bausch + Lomb Commences Tender Offer of Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3 and U07190AA6)
2. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
3. Bausch + Lomb Names John Barr Global President Surgical
4. TWi Pharmaceuticals Announces Positive Phase IIb Clinical Trial Results of AC-201 in Patients with Type 2 Diabetes.
5. Pro-Dex, Inc. Announces Update Conference Call and Webcast
6. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
7. Cardica Announces Fiscal 2012 Fourth Quarter And Year End Financial Results
8. Law Office of Brodsky & Smith, LLC Announces Settlements of Yaz, and Yasmin Cases
9. BD Announces Results For 2012 Third Fiscal Quarter
10. Alexza Announces Management Promotions
11. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013  NxStage Medical, Inc. (Nasdaq: NXTM ... announced that it has entered into new agreements covering ... to DaVita, the kidney care division of DaVita Healthcare Partners ... For the use of products for home hemodialysis ... has executed a second amended and restated National Service ...
(Date:5/21/2013)... New data released today at the ... that the NeuroStar TMS Therapy System ® ... in patients with Major Depressive Disorder (MDD) during ... through one year of treatment.  At the end ... symptomatic improvement while 41 percent reported complete remission. ...
(Date:5/21/2013)... Quebec , May 21, 2013 ... (NYSE: VRX ) (TSX: ... ten directors nominated at its 2013 ... detailed results of the vote for ... out below:  NameForWithheldRonald H. Farmer235,731,9341,964,748Robert A. ...
Breaking Medicine Technology:NxStage Announces New Agreements with DaVita 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 4Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2
... and NEEDHAM, Mass., March 19, 2012  Oridion (SIX ... Index™, one of the Smart Capnography™ family of ... survey conducted at the October 2011 ... (ASA) conference in Chicago. Respondents showed a clear preference ...
... International, Inc. (SGLN.PK) and SurgLine, Inc. ("SurgLine") today announced ... SurgLine have completed the return of over 1,000,000,000 shares of ... up to the previous press release whereby the executives of ... of the restricted shares they were issued of SGLN in ...
Cached Medicine Technology:Survey Shows Anesthesiologists Prefer Capnography for Monitoring Adequacy of Ventilation 2Survey Shows Anesthesiologists Prefer Capnography for Monitoring Adequacy of Ventilation 3Survey Shows Anesthesiologists Prefer Capnography for Monitoring Adequacy of Ventilation 4SurgLine International, Inc. Announces Over 1 Billion Shares Returned to Company 2
(Date:5/21/2013)... from SOURCE XT one of the largest, post-approval ... today at EuroPCR 2013 show good clinical outcomes in ... for all access approaches, valve sizes and delivery systems. ... consecutively enrolled patients (mean age 81.5 years) undergoing TAVI ... in 17 countries between July 2010 and October 2011. ...
(Date:5/21/2013)... 2013, Paris, France: The Orsiro stent, which is ... biodegradable polymer, demonstrated non-inferiority to the Xience Prime ... in-stent late lumen loss at nine months in ... EuroPCR 2013 today. , The BIOFLOW-II substudy used ... to quantitatively assess neointimal hyperplasia and stent apposition ...
(Date:5/21/2013)... AZ (PRWEB) May 21, 2013 ... and inventors who want to develop their ideas ... summer program. , The university is recruiting ... revolutionary new “formation space” that provides early-stage entrepreneurs ... While AREA48 is open to anyone, ASU is ...
(Date:5/21/2013)... According to a May 13, 2013 New ... Botox,” Botox injections have become the most popular ... (Go to goo.gl/8iYbD). Although it is mostly associated with women, ... injection makes facial wrinkles less visible by paralyzing facial muscles. ... three months. This means that people who are conscious about ...
(Date:5/21/2013)... 21, 2013 The federal judge overseeing ... lawsuits in U.S. District Court, Northern District ... a request from Plaintiffs’ Counsel to conduct Ex Parte ... May 17th Order grants that request, and sets forth ... re: Wright Medical Technology, Inc., Conserve Hip Implant Products ...
Breaking Medicine News(10 mins):Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3
... completes successful first year , ... Monrovia, Liberia (Vocus) ... increased access to health care for Liberia,s citizens is the availability ... of rebuilding, much of the country,s infrastructure is still in ruins, ...
... of the most debilitating diseases known to man, and new findings ... News Report website. To read the entire report about the ... , ... Boca Raton, Fla. (PRWEB) November 14, 2008 ...
... school, dips in academic performance and classroom participation can ... students to accept newcomers can go a long way ... the conclusion of a new longitudinal study that found ... to declines in academic performance and classroom participation, but ...
... VIRGINIA BEACH, Va., Nov. 13, 2008 James G.,Carlson, Chairman ... statement on America,s "Premature Birth Report Card," which was,released November ... in America deserves a fair chance to grow up in ... clear with its ,Premature,Birth Report Card, that is not the ...
... Marks for its Lack of Overall Plan and,Sense of ... (LCA-CA) issued its 1st annual Report Card on Lung ... to the state for its lack,of progress in reducing ... year than all other major cancer combined., (Logo: ...
... fourth annual EagleBank,Foundation Fight Breast Cancer Golf Classic ... primary beneficiaries: Shady Grove,Adventist Hospital and Suburban Hospital ... Hospital, Providence Hospital and Washington,Hospital Center in Washington, ... Montgomery County. The tournament was held on October ...
Cached Medicine News:Health News:Mercy Ships Ensures That Liberian Technicians "know how to fix it" 2Health News:Mercy Ships Ensures That Liberian Technicians "know how to fix it" 3Health News:Mercy Ships Ensures That Liberian Technicians "know how to fix it" 4Health News:Alzheimer's Disease Cutting Edge Research Announced on Natural Health News Report Website 2Health News:Supportive teachers, peers can ease negative effects of frequent moves in elementary school 2Health News:AMERIGROUP Chairman and CEO Urges Action to Improve Nation's 'Premature Birth Report Card' 2Health News:Lung Cancer Alliance-California Issues Inaugural State-Specific Report Card on Lung Cancer 2Health News:Fourth Annual EagleBank Foundation Fight Breast Cancer Golf Classic Raises Over $100,000 2
Polyester ribbon impregnated with conjugated Protein A - .25 OD per sq. cm....
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Colloidal Gold Sol, 40 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 30 nm 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: